Ramsey Cheung
Publications
- The impact of chronic hepatitis C and co-morbid illnesses on health-related quality of life. Qual Life Res. 2008; (5): 715-24
- A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology. 2007; (2): 297-306
- Incidence of statin hepatotoxicity in patients with hepatitis C. Clin Gastroenterol Hepatol. 2006; (7): 902-7; quiz 806
- Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol. 2000; (3): 740-7
- Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines. J Clin Gastroenterol. 2013; (3): 264-70
- Implications of rapid virological response in hepatitis C therapy in the US veteran population. Aliment Pharmacol Ther. 2012; (1): 105-15
- Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for entecavir partial responders. Dig Dis Sci. 2012; (11): 3011-6
- Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the US. Dig Dis Sci. 2010; (6): 1744-51
- Adenovirus-induced acute liver failure. Dig Dis Sci. 2009; (2): 218-21
- Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice? J Clin Gastroenterol. 2008; (7): 827-34
- Diagnostic markers for hepatitis virus infection Expert Opinion Med Diagnostics. 2008: 303-314
- Monitoring of epithelial cell caspase activation via detection of durable keratin fragment formation. J Pathol. 2008; (2): 164-74
- Persistence with hepatitis C therapy in the Department of Veterans Affairs. J Clin Pharm Ther. 2008; (3): 251-61
- Treatment eligibility and outcomes in elderly patients with chronic hepatitis C: results from the VA HCV-001 Study. Dig Dis Sci. 2008; (3): 809-14
- Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans. Dig Dis Sci. 2007; (2): 570-8
- Hepatitis C treatment candidacy and outcomes among 4318 US veterans with chronic hepatitis C virus infection: does a history of injection drug use matter? J Clin Gastroenterol. 2007; (2): 199-205
- Positive CAGE screen correlates with cirrhosis in veterans with chronic hepatitis C. Dig Dis Sci. 2007; (10): 2564-9
- Alcohol use and treatment of hepatitis C virus: results of a national multicenter study. Gastroenterology. 2006; (6): 1607-16
- Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*. J Viral Hepat. 2006; (4): 242-9
- Effectiveness of a screening program for hepatitis C. Dig Dis Sci. 2006; (5): 976-81
- Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology. 2006; (2): 352-9
- Hepatitis B vaccines. Infect Dis Clin North Am. 2006; (1): 27-45
- Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology. 2006; (6): 1679-87
- Phenotypic and functional status of intrahepatic T cells in chronic hepatitis C. J Infect Dis. 2006; (8): 1068-77
- Screening for esophageal varices in cirrhotic patients: endoscope, platelet count, or both? Gastrointest Endosc. 2006; (6): 865-7
- The impact of chronic hepatitis C and comorbid psychiatric illnesses on health-related quality of life. J Clin Gastroenterol. 2006; (6): 528-34
- A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C. Antivir Ther. 2005; (5): 635-43
- Amantadine in treatment of chronic hepatitis C virus infection? J Viral Hepat. 2005; (5): 445-55
- Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes. Am J Gastroenterol. 2005; (10): 2186-93
- High mortality rate in patients with advanced liver disease independent of exposure to general anesthesia. J Clin Anesth. 2005; (3): 172-6
- Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol. 2005; (8): 1772-9
- Expression of chemokine receptors on intrahepatic and peripheral lymphocytes in chronic hepatitis C infection: its relationship to liver inflammation. J Infect Dis. 2004; (5): 989-97
- Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C. J Med Virol. 2004; (4): 575-85
- Hepatitis B vaccines. Clin Liver Dis. 2004; (2): 283-300
- The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection. J Immunol Methods. 2004; (1-2): 91-9
- Determination of hepatitis C virus genotype by Pyrosequencing. J Virol Methods. 2003; (2): 171-6
- Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C. Hepatology. 2003; (3): 610-21
- The impact of hepatitis C status on postoperative outcome. Anesth Analg. 2003; (2): 550-4, table of contents
- Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis C. Am J Gastroenterol. 2002; (10): 2640-6
- Viral hepatitis and other infectious diseases in a homeless population. J Clin Gastroenterol. 2002; (4): 476-80
- Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy. Am J Gastroenterol. 2001; (1): 233-7
- Endoscopic gastrointestinal manifestations of liver disease. Gastrointest Endosc Clin N Am. 2001; (1): 15-44
- Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis. 2001; (7): 827-35
- Treating chronic Hepatitis C patients with psychiatric disorders: an uphill battle. Am J Gastroenterol. 2001; (1): 3-4
- Management of gallstones and their complications. Am Fam Physician. 2000; (6): 1673-80, 1687-8
- Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A. 1999; (10): 5692-7
- Finding the iron in the melting pot--practical use of a new genetic assay for hereditary hemochromatosis. West J Med. 1998; (6): 525-7
- Hepatitis G virus: clinical relevance and responsiveness to interferon. Am J Gastroenterol. 1997; (11): 1957-9
- Hepatitis G virus: is it a hepatitis virus? West J Med. 1997; (1): 23-33
- Hepatitis C virus detection by single-round PCR specific for the terminal 3' noncoding region. J Clin Microbiol. 1996; (10): 2552-8
- A cell surface protein that binds avian hepatitis B virus particles. J Virol. 1994; (4): 2091-6
- Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J Virol. 1994; (10): 6147-60
- Rapid and sensitive method for detection of hepatitis C virus RNA by using silica particles. J Clin Microbiol. 1994; (10): 2593-7
- Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative Study. Kidney Int. 1994; (3): 886-92
- Longitudinal study of hepatitis C viremia in chronic hepatitis C. J Med Virol. 1993; (4): 338-42
- Hepatitis C viremia in patients with hepatitis C virus infection. Hepatology. 1992; (6): 1007-12
- Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide. Virology. 1991; (1): 14-21
- Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks. Virology. 1990; (2): 546-52
- Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus. J Virol. 1989; (6): 2445-51
Help
Trial Administration